XML 57 R41.htm IDEA: XBRL DOCUMENT v3.25.4
Income Taxes - (Tables)
 12 Months Ended
Jan. 31, 2026
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
The domestic and international components of the Company's income (loss) from operations before income taxes are as follows:
Fiscal year ended January 31,
(in thousands)202620252024
Domestic$33,480 $(33,349)$(4,444)
International6,646 5,291 4,106 
Income (loss) from operations before income taxes
$40,126 $(28,058)$(338)
Schedule of Components of Income Tax Expense (Benefit) The Company's (provision for) benefit from income taxes is comprised of the following:
Fiscal year ended January 31,
(in thousands)202620252024
Current:
   Federal$(180)$(63)$(43)
   State(415)(1,359)(912)
   International(1,766)(1,893)(1,262)
   Total current(2,361)(3,315)(2,217)
Deferred:
   Federal112 2,378 (4)
   State6 1,007 (11)
   International(12)40 (60)
   Total deferred106 3,425 (75)
Total (provision for) benefit from income taxes
$(2,255)$110 $(2,292)
Schedule of Effective Income Tax Rate Reconciliation The following table is a reconciliation of the U.S. federal statutory rate of 21% to the Company's effective tax rate for the year ended January 31, 2026 in accordance of the guidance in ASU 2023-09:
Fiscal year ended January 31, 2026
(in thousands)
Dollars
Percent
U.S. Federal Statutory Tax Rate$8,426 21.00%
State and local income tax, net of federal income tax effect(1)
408 1.02%
Foreign tax effects:
Switzerland
  Adjustments to deferred tax assets (NOL expiration)
707 1.76%
  FX adjustment
(603)(1.50%)
  Other(118)(0.29%)
Other foreign jurisdictions396 0.99%
Effect of cross-border tax laws:
  Global intangible low-taxed income1,062 2.65%
  Other191 0.47%
Tax Credits:
   R&D credit(2,532)(6.31%)
Changes in valuation allowances(2,479)(6.18%)
Nontaxable or nondeductible items:
  Stock-based compensation1,814 4.52%
  Executive compensation2,461 6.13%
  Contingent consideration (6,336)(15.79%)
  Other1,469 3.66%
Changes in unrecognized tax benefits(28)(0.07%)
Other223 0.55%
Excess tax benefits(2,806)(6.99%)
Total tax provision$2,255 5.62%
(1)    State taxes in California, Pennsylvania, Texas, and Virginia made up the majority (greater than 50 percent) of the tax effect in this category.
The following table is a reconciliation of the U.S. federal statutory rate of 21% to the Company's effective tax rate for the year ended January 31, 2025 and 2024 in accordance with the guidance prior to the adoption of ASU 2023-09:
Fiscal year ended January 31,
(in thousands)20252024
U.S. federal tax benefit at statutory rate$5,892 $71 
State taxes, net of federal benefit2,711 (1,286)
Foreign tax rate differential(317)(191)
Non-deductible expenses(2,209)(1,902)
R&D credit carryforward3,725 15,656 
Changes in valuation allowance(2,133)(13,913)
Rate change(1)386 
Stock-based compensation(758)(1,593)
Net excess tax (shortfalls) benefits from stock-based compensation(1,334)213 
Return to provision adjustment(56)(25)
Global intangible low-taxed income(1,191)— 
Acquisition-related costs(3,532)— 
Other, net(687)292 
Total benefit from (provision for) income taxes $110 $(2,292)
Schedule of Cash Flow, Supplemental Disclosures
The following table represents income taxes paid (net of refund received) for the year ended January 31, 2026 in accordance with the guidance in ASU 2023-09:
(in thousands)Fiscal Year Ended January 31, 2026
Federal$— 
State873 
Foreign2,696 
Total income taxes paid$3,569 
Income taxes paid in individual jurisdictions exceeding 5% of total income taxes paid for the year ended January 31, 2026 is as follows:
(in thousands)Fiscal Year Ended January 31, 2026
United Kingdom$763 
France409
Mexico348
California334
India391
Germany238
Hungary$230 
Schedule of Deferred Tax Assets and Liabilities The components of the Company's deferred income taxes were as follows:
As of January 31,
(in thousands)20262025
Deferred tax assets:
  Net operating loss carryforwards$109,034 $97,463 
  Tax credit carryforwards25,007 22,577 
  Stock-based compensation4,484 5,905 
  Allowance for doubtful accounts598 524 
  Operating lease liability19,134 23,392 
  Accrued expenses3,736 6,420 
Unearned revenue81 65 
Property and equipment1,373 199 
  Capitalized research & experimental expenditures32,678 51,062 
  Other2,325 1,451 
  Total deferred tax assets198,450 209,058 
  Less: valuation allowance(168,940)(171,650)
  Deferred tax assets, net of valuation allowance29,510 37,408 
Deferred tax liabilities:
  Costs to obtain revenue contracts(5,820)(5,916)
  Operating lease right-of-use assets (12,001)(16,638)
  Intangible assets(11,413)(14,427)
  Other(438)(533)
  Total deferred tax liabilities(29,672)(37,514)
Net deferred tax liabilities
$(162)$(106)
Reconciliation of Unrecognized Tax Benefits Roll Forward
A reconciliation of the beginning and ending balance of total unrecognized tax benefits for the fiscal years ended January 31, 2026, 2025, and 2024 is as follows:
Fiscal year ended January 31,
(in thousands)202620252024
Beginning of period$6,531 $4,920 $— 
Tax positions taken in prior period
Gross increases— 942 4,404 
Gross decreases(27)— — 
Tax positions taken in current period
Gross increases670 669 516 
Currency translation effect— — — 
End of period$7,174 $6,531 $4,920